Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Durvalumab in Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03094286
Recruitment Status : Active, not recruiting
First Posted : March 29, 2017
Last Update Posted : February 2, 2021
Information provided by (Responsible Party):
Spanish Lung Cancer Group